Podcast Episode 13: Generic Drugs for Parkinson’s

PD Library thumbnail

Generic drugs are a cheaper alternative to brand name drugs. But are they as effective? Once the patent on a branded drug expires, other companies are free to apply for approval of a generic version – a drug that acts in the body largely the same as the branded one. Dr. Rajesh Pahwa of the University of Kansas, a Parkinson’s Foundation Center of Excellence, describes how generics compare to brand name products and what to look for, and look out for, when getting a generic or making the switch.

Download This Episode

Related Resources

Want More?

Don't forget to subscribe! There are many ways to listen: Apple PodcastsGoogle PlayTuneIn (Amazon Echo), Spotify or RSS Feed. (Need help subscribing? See our quick guide.)

For all of our Substantial Matters podcast episodes, visit parkinson.org/podcast.

About This Episode

Released: October 10, 2017

Rajesh Pahwa, MD

Dr. Pahwa is the Laverne and Joyce Rider Professor of Neurology at the University of Kansas Medical Center. He is also Chief, Parkinson and Movement Disorder Division and Director of the Parkinson’s Foundation Center of Excellence at the University of Kansas Medical Center, Kansas City, Kansas.

Dr. Pahwa received his MBBS (MD) degree at Seth G.S. Medical College, University of Bombay, India. He completed an internship in medicine at Baylor College of Medicine followed by a residency in Neurology at Baylor College of Medicine, Houston, Texas. He then completed a fellowship in movement disorders at the University of Kansas Medical Center. Dr. Pahwa is a Diplomate of the American Board of Psychiatry and Neurology.

Dr. Pahwa's research interests are centered around the various aspects of Parkinson's disease and essential tremor. He is currently involved in studies related to medical and surgical therapies for both disorders. Dr. Pahwa has published more than 250 peer-reviewed articles, chapters, and abstracts in leading neurology and movement disorder journals. He has conducted more than 100 clinical trials related to Parkinson's disease and other movement disorders. He is the co-editor of "Handbook of Parkinson's Disease," 3rd and 4th editions; "Therapy of Parkinson's Disease," 3rd edition; and "Handbook of Essential Tremor and Other Tremor Disorders." He is co-author of the book "Parkinson's Disease: Questions and Answers," 4th edition.

This episode of Substantial Matters was made possible through the generous donations of thousands of people affected by Parkinson’s and a grant from Mylan.


Sign Up for Our E-Newsletter

Get the latest news about PD research, resources and community initiatives – straight to your inbox.

Please enter a valid email

Skip step

Invalid year format. Eg: 2020
Skip step
Zip code is required for chapter communications
Skip step

*Please note that not all content is available in both languages. If you are interested in receiving Spanish communications, we recommend selecting “both" to stay best informed on the Foundation's work and the latest in PD news.

Skip step

Thanks for Signing Up

We are proud to have you as a part of our community. To ensure you receive the latest Parkinson’s news, research updates and more, please check your email for a message from us. If you do not see our email, it may be in your spam folder. Just mark as “not spam” and you should receive our emails as expected.

mail icon

Subscribe here to get the latest news on treatments, research and other updates.